Cargando…
Brachyury, a driver of tumor invasiveness and resistance to multiple therapies, is a novel immunotherapy target
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990333/ http://dx.doi.org/10.1186/2051-1426-1-S1-P230 |